| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $6.0M | +43.9% |
| R&D Expense | $5.7M | +0.7% |
| SG&A Expense | $42.7M | -3.9% |
| Operating Income | -$11.7M | -15.7% |
| Pre-tax Income | -$9.5M | -26.1% |
| Income Tax | $1.9M | +17.3% |
| Net Income | -$11.4M | -24.6% |
| EPS (Basic) | -$0.61 | -24.5% |
| EPS (Diluted) | -$0.61 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.4M | -21.8% |
| Current Assets | $60.8M | -16.8% |
| Total Assets | $333.1M | +2.5% |
| Current Liabilities | $27.2M | +51.5% |
| Total Liabilities | $176.5M | +7.7% |
| Stockholders' Equity | $156.6M | -2.8% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.3M | -169.7% |
| Capital Expenditures | $87K | -71.7% |
| Investing Cash Flow | $22.8M | +181.3% |
| Financing Cash Flow | -$6.6M | +73.8% |
| Free Cash Flow | -$29.4M | -170.4% |
| -24.5% |